Athena Capital Advisors »

Regeneron Pharmaceuticals shares owned by Athena Capital Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Athena Capital Advisors from 13F filings

Historical chart of Athena Capital Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Athena Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Athena Capital Advisors

Quarter filed Position value Share count Share price at filing
2020-06-30 $337k 540 624.07
2020-03-31 $264k 540 488.89
2018-12-31 $2.0k 5 400.00

More positions owned by Athena Capital Advisors

Thermo Fisher Scientific (TMO)
SPDR S&P 500 ETF Trust Tr Unit (SPY)
iShares Gold Trust Ishares
Nordson Corporation (NDSN)
Apple (AAPL)
iShares Russell 3000 ETF Russell 3000 Etf (IWV)
Alphabet Inc., Class C Shares Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Progressive Corporation (PGR)
Alphabet Inc., Class A Shares Cap Stk Cl A (GOOGL)
Solaredge Technologies (SEDG)
Johnson & Johnson (JNJ)
Eaton Corp SHS (ETN)
Vanguard FTSE Developed Markets ETF Ftse Dev Mkt Etf (VEA)
Home Depot (HD)

View all positions for Athena Capital Advisors

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals